Validity of 6 Minutes Stepper Test in Hypertension
Validity and Reliability of 6 Minutes Stepper Test in Hypertensive Patients
1 other identifier
observational
40
1 country
1
Brief Summary
The six minutes stepper test (6MST) was used assess exercise capacity of individuals having different chronic conditions. In the literature, there are some validation studies analyzing validity of 6MST. In this study, the main aim was to analyse validation of 6MST in hypertensive individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 17, 2023
CompletedOctober 17, 2023
October 1, 2023
6 months
September 17, 2023
October 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
exercise capacity
steps during 6MST
through study completion two day
functional capacity
walking distance during 6MWT
through study completion two day
Study Arms (1)
Hypertensive Individuals
Patients diagnosed with arterial hypertension
Interventions
Patients were applied two 6MST and 6MWT. 6MWT was conducted to test convergent validity of 6MST.
Eligibility Criteria
Diagnosed with systemic (arterial) hypertension and convenient with inclusion and exclusion criterias.
You may qualify if:
- Being 18 to 65 years,
- Diagnosed with hypertension and willing to participate the study.
You may not qualify if:
- having a neurological, cognitive and/or orthopedic disease that affect the measurements,
- severe respiratory disease (FEV1 \< 35%; FVC \< 50%),
- presence of acute infection,
- any malignancy,
- dementia,
- any cardiovascular event in the last 6 months,
- uncontrolled hypertension and diabetes
- body mass index (BMI) higher than 40 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ebru Calik Kutukcu, PhD
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 17, 2023
First Posted
October 17, 2023
Study Start
June 1, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
October 17, 2023
Record last verified: 2023-10